
The start-up will launch a cycle-synced lifestyle app to help women manage their hormonal health

Endometrial cancer is the most commonly diagnosed gynaecologic cancer in American women

The app has benefitted from a complete redesign and redevelopment to provide clear visual learning for latching

This week we meet Hélène Guillaume, founder and CEO of the WILD.AI app

Second novel PCOS drug target from Celmatix-Evotec Alliance progresses into hit-identification

The developers believe the test will help drive the development of new therapeutics for endometriosis

The round brings the company's total funding to US$22.3m, underscoring the need to rebuild US maternity care services

By Misbah Mahmood, digital midwife, Leeds Teaching Hospitals NHS Trust

Phexxi will be the first and only hormone-free contraceptive offered by Favor

The clinic has previously raised €17m in funding to expand to Spain, Germany and Italy